ICU Medical, Inc. (ICUI): Price and Financial Metrics
GET POWR RATINGS... FREE!
ICUI POWR Grades
- ICUI scores best on the Growth dimension, with a Growth rank ahead of 76.71% of US stocks.
- The strongest trend for ICUI is in Stability, which has been heading down over the past 179 days.
- ICUI's current lowest rank is in the Momentum metric (where it is better than 1.14% of US stocks).
ICUI Stock Summary
- The price/operating cash flow metric for ICU MEDICAL INC is higher than 98.01% of stocks in our set with a positive cash flow.
- Over the past twelve months, ICUI has reported earnings growth of -113.93%, putting it ahead of only 13.17% of US stocks in our set.
- ICU MEDICAL INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -44.54%, greater than the shareholder yield of only 11.91% of stocks in our set.
- Stocks that are quantitatively similar to ICUI, based on their financial statements, market capitalization, and price volatility, are NUVA, ASTE, FNA, PRGO, and SEMR.
- ICUI's SEC filings can be seen here. And to visit ICU MEDICAL INC's official web site, go to www.icumed.com.
ICUI Valuation Summary
- In comparison to the median Healthcare stock, ICUI's price/sales ratio is 10% lower, now standing at 1.8.
- Over the past 243 months, ICUI's EV/EBIT ratio has gone down 303.5.
Below are key valuation metrics over time for ICUI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ICUI | 2022-11-25 | 1.8 | 1.9 | -97.3 | -285.1 |
| ICUI | 2022-11-23 | 1.9 | 1.9 | -97.5 | -285.7 |
| ICUI | 2022-11-22 | 1.8 | 1.9 | -97.3 | -285.2 |
| ICUI | 2022-11-21 | 1.9 | 1.9 | -97.6 | -285.7 |
| ICUI | 2022-11-18 | 1.8 | 1.9 | -96.9 | -284.3 |
| ICUI | 2022-11-17 | 1.8 | 1.9 | -96.2 | -282.8 |
ICUI Growth Metrics
- Its 3 year price growth rate is now at -12.12%.
- The 5 year net cashflow from operations growth rate now stands at 80.62%.
- Its 3 year net income to common stockholders growth rate is now at -24.73%.
The table below shows ICUI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 2,042.508 | 22.203 | -38.825 |
| 2022-06-30 | 1,780.711 | 98.729 | 5.464 |
| 2022-03-31 | 1,541.384 | 214.876 | 41.336 |
| 2021-12-31 | 1,316.308 | 267.538 | 103.135 |
| 2021-09-30 | 1,296.234 | 263.443 | 109.352 |
| 2021-06-30 | 1,278.741 | 260.094 | 103.257 |
ICUI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ICUI has a Quality Grade of B, ranking ahead of 76.17% of graded US stocks.
- ICUI's asset turnover comes in at 0.724 -- ranking 47th of 186 Medical Equipment stocks.
- ABMD, ECIA, and STXS are the stocks whose asset turnover ratios are most correlated with ICUI.
The table below shows ICUI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.724 | 0.368 | 0.127 |
| 2021-03-31 | 0.708 | 0.359 | 0.111 |
| 2020-12-31 | 0.709 | 0.363 | 0.104 |
| 2020-09-30 | 0.713 | 0.360 | 0.094 |
| 2020-06-30 | 0.716 | 0.367 | 0.102 |
| 2020-03-31 | 0.747 | 0.362 | 0.110 |
ICUI Price Target
For more insight on analysts targets of ICUI, see our ICUI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $296.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
ICUI Stock Price Chart Interactive Chart >
ICUI Price/Volume Stats
| Current price | $161.44 | 52-week high | $251.73 |
| Prev. close | $162.70 | 52-week low | $128.90 |
| Day low | $160.45 | Volume | 87,200 |
| Day high | $163.29 | Avg. volume | 201,294 |
| 50-day MA | $150.64 | Dividend yield | N/A |
| 200-day MA | $180.45 | Market Cap | 3.87B |
ICU Medical, Inc. (ICUI) Company Bio
ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.
Latest ICUI News From Around the Web
Below are the latest news stories about ICU MEDICAL INC that investors may wish to consider to help them evaluate ICUI as an investment opportunity.
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue EstimatesICU Medical (ICUI) delivered earnings and revenue surprises of 24.11% and 6.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? |
ICU Medical Announces Third Quarter 2022 ResultsThe Company Reaffirms 2022 Fiscal Year GuidanceSAN CLEMENTE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2022. Third Quarter 2022 Results Third quarter 2022 revenue was $597.9 million, compared to $336.1 million in the same period last year. GAAP gross profit for the third quarter of 2022 was $186.4 million, as comp |
As ICU Medical, Inc. (NASDAQ:ICUI) drops to US$3.3b market cap, insiders might rethink their US$4.5m stock purchase earlier this yearThe recent price decline of 8.6% in ICU Medical, Inc.'s ( NASDAQ:ICUI ) stock may have disappointed insiders who bought... |
FDA Signals Shortage Of ICU Medical's Tracheostomy TubesThe FDA said there was a shortage of tracheostomy tubes, including Bivona tracheostomy tubes manufactured by ICU Medical Inc (NASDAQ: ICUI). The agency said the shortage was due to difficulties in raw material procurement and would most likely impact pediatric patients. A shortage of Bivona tracheostomy tubes is more likely to impact pediatric patients because the supply of alternative tubes with similar functionality may be limited. Bivona tracheostomy tube is commonly used in pediatric patient |
UPDATE 1-U.S. FDA warns of tracheostomy tube shortageU.S. Food and Drug Administration (FDA) said on Monday there was a shortage of tracheostomy tubes, a surgical device that helps patients to breathe, including those manufactured by ICU Medical. The agency said the shortage was due to difficulties in raw material procurement and would most likely impact pediatric patients. They will be affected by the limited supply of tubes with similar functionality as ICU Medical's Bivona, that are made from flexible silicone and easier to use in children. |
ICUI Price Returns
| 1-mo | 18.35% |
| 3-mo | N/A |
| 6-mo | -9.59% |
| 1-year | -26.94% |
| 3-year | -12.37% |
| 5-year | -20.53% |
| YTD | -31.98% |
| 2021 | 10.65% |
| 2020 | 14.63% |
| 2019 | -18.51% |
| 2018 | 6.31% |
| 2017 | 46.59% |
Continue Researching ICUI
Want to do more research on Icu Medical Inc's stock and its price? Try the links below:Icu Medical Inc (ICUI) Stock Price | Nasdaq
Icu Medical Inc (ICUI) Stock Quote, History and News - Yahoo Finance
Icu Medical Inc (ICUI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...